PetMed Express PETS 深 沪
交易中 11-06 10:43:48 美东时间
1.20
-0.040
-3.23%
华盛通- 最 高1.22
- 今 开1.22
- 成交量 1.15万股
- 最 低 1.20
- 昨 收 1.24
- 总市值 2601.47万
- 52周最高 4.10
- 市盈率 静 --
- 换手率 0.05%
- 52周最低 1.15
- 委 比 -4.31%
- 总股本 2167.89万
- 历史最高 53.72
- 量 比 1.98
- 振 幅 1.61%
- 历史最低 -1.015
- 每 手 1
- 风险率 0.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PetMed Express收涨0.84%，成交额4.17万美元
11月3日，PetMed Express（PETS）收涨0.84%，报1.2美元，成交额4.17万美元，市值2601.47万美元。 行情数据 • 开盘价：1....
11-03 08:40
PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026
PetMed Express, Inc. (Nasdaq: PETS), doing business as PetMeds and parent company of PetCareRx, announced it will report second quarter fiscal year 2026 financial results on Tuesday, November 10, 2026, after market close. A conference call and webcast to review the results will be held at 4:30pm Eastern Time on the same day. The webcast link and dial-in numbers are provided. A replay of the call will be available starting at 7:30pm Eastern Time o...
10-27 20:15
PetMed Express收跌4.92%，成交额11.17万美元
10月27日，PetMed Express（PETS）收跌4.92%，报1.16美元，成交额11.17万美元，市值2514.75万美元。 行情数据 • 开盘价...
10-27 07:43
PetMed Express收跌3.28%，成交额22.09万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:47
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PetMeds granted equity awards to two new executives under its 2024 Inducement Incentive Plan. Jeff Willard received 250,000 restricted shares and 250,000 PSUs tied to shareholder return targets, while Andrew Parry received 100,000 restricted shares. The awards vest over three years and align with Nasdaq Listing Rule 5635(c)(4).
10-02 20:05
美股大行评级 | Meta获4家机构看好！目标价最高升至950美元；好市多绩后齐遭机构降低目标价
今日重点评级关注：古根海姆：维持Damora Therapeutics"买入"评级，目标价从40美元升至60美元；HC Wainwright & Co.：维持Rezolute"买入"评级，目标价从5美元升至10美元
09-28 12:37
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $2.15 to $1.4.
09-26 00:51
PetMed Express adds human capital expert to board
Petmed Express ( ($PETS) ) has provided an update. On September 17, 2026, PetMe...
09-21 20:58
PetMed Express Names Jeff Willard CEO Amid Transformation
Petmed Express ( ($PETS) ) has issued an update. PetMed Express announced on Se...
09-17 21:28
PetMeds Appoints Andrew Parry as Chief Technology Officer
PetMeds appoints Andrew Parry as Chief Technology Officer. With over 30 years of experience, Parry joins from The ODP Corporation, where he led technology initiatives and platform modernization. He will oversee technology strategy, e-commerce, and pharmacy systems at PetMeds. Parry aims to enhance platforms, optimize performance, and improve customer experience.
09-14 20:05
